{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:12:14Z","timestamp":1770347534085,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1378\/chest.120.6.1888","type":"journal-article","created":{"date-parts":[[2003,6,13]],"date-time":"2003-06-13T20:09:19Z","timestamp":1055534959000},"page":"1888-1893","source":"Crossref","is-referenced-by-count":116,"title":["Pulmonary Manifestations of HIV Infection in the Era of Highly Active Antiretroviral Therapy"],"prefix":"10.1016","volume":"120","author":[{"given":"Armand J.","family":"Wolff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne E.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.120.6.1888_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jama.284.2.223","article-title":"Immune restoration with antiretroviral therapies: implications for clinical management","volume":"284","author":"Lederman","year":"2000","journal-title":"JAMA"},{"key":"10.1378\/chest.120.6.1888_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0165-2478(98)00159-X","article-title":"Restoration of the immune system with anti-retroviral therapy","volume":"66","author":"Autran","year":"1999","journal-title":"Immunol Lett"},{"key":"10.1378\/chest.120.6.1888_bib3","doi-asserted-by":"crossref","first-page":"F217","DOI":"10.1097\/00002030-199817000-00002","article-title":"Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy","volume":"12","author":"Kroon","year":"1998","journal-title":"AIDS"},{"key":"10.1378\/chest.120.6.1888_bib4","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0140-6736(00)02069-9","article-title":"Survival after introduction of HAART in people with known duration of HIV-1 infection: concerted action on seroconversion to AIDS and death in Europe","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1378\/chest.120.6.1888_bib5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/BF02390528","article-title":"Impact of HAART on causes of death of persons with late-stage AIDS","volume":"77","author":"Sansone","year":"2000","journal-title":"J Urban Health"},{"key":"10.1378\/chest.120.6.1888_bib6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00126334-200008010-00013","article-title":"Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: a 5-year prospective study","volume":"24","author":"Hung","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1378\/chest.120.6.1888_bib7","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy","volume":"30","author":"Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.120.6.1888_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/ajrccm.162.1.9904101","article-title":"Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection","volume":"162","author":"Sullivan","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.120.6.1888_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00126334-200002010-00006","article-title":"HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era","volume":"23","author":"Tumbarello","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1378\/chest.120.6.1888_bib10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/jnnp.69.3.376","article-title":"Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART)","volume":"69","author":"Maschke","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1378\/chest.120.6.1888_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1572-0241.2000.01768.x","article-title":"Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy","volume":"95","author":"M\u00f6nkem\u00fcller","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1378\/chest.120.6.1888_bib12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1164\/ajrccm.162.3.9908018","article-title":"Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy: EuroSIDA Study Group","volume":"162","author":"Kirk","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.120.6.1888_bib13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/bjo.83.6.652","article-title":"Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study","volume":"83","author":"Mitchell","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1378\/chest.120.6.1888_bib14","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1212\/WNL.54.9.1856","article-title":"Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy","volume":"54","author":"d'Armino Monteforte","year":"2000","journal-title":"Neurology"},{"issue":"RR-10","key":"10.1378\/chest.120.6.1888_bib15","article-title":"USPHS\/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus","volume":"48","author":"USPHS\/IDSA","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1378\/chest.120.6.1888_bib16","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(99)03287-0","article-title":"Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection: EuroSIDA Study Group","volume":"353","author":"Weverling","year":"1999","journal-title":"Lancet"},{"key":"10.1378\/chest.120.6.1888_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00002030-200003100-00011","article-title":"Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy","volume":"14","author":"Soriano","year":"2000","journal-title":"AIDS"},{"key":"10.1378\/chest.120.6.1888_bib18","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/00002030-199909100-00007","article-title":"Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?","volume":"13","author":"Kirk","year":"1999","journal-title":"AIDS"},{"key":"10.1378\/chest.120.6.1888_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200101183440301","article-title":"A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection","volume":"344","author":"Lopez Bernaldo de Quiros","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.120.6.1888_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM200101183440302","article-title":"Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy","volume":"344","author":"Ledergerber","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.120.6.1888_bib21","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1378\/chest.117.4.1128","article-title":"The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma","volume":"117","author":"Aboulafia","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.120.6.1888_bib22","first-page":"S31","article-title":"Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants","volume":"21","author":"Rabkin","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1378\/chest.120.6.1888_bib23","first-page":"S18","article-title":"Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center","volume":"21","author":"Sparano","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1378\/chest.120.6.1888_bib24","first-page":"S23","article-title":"Combination antiretroviral therapy and incidence of AIDS-related malignancies","volume":"21","author":"Buchbinder","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1378\/chest.120.6.1888_bib25","first-page":"S34","article-title":"Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma among HIV-1 infected individuals","volume":"21","author":"Jacobson","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1378\/chest.120.6.1888_bib26","first-page":"442","article-title":"Acquired immunodeficiency syndrome-related lymphoma: clinical aspects","volume":"27","author":"Levine","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1378\/chest.120.6.1888_bib27","first-page":"390","article-title":"The epidemiology of acquired immunodeficiency syndrome malignancies","volume":"27","author":"Goedert","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1378\/chest.120.6.1888_bib28","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0889-8588(05)70386-5","article-title":"Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma","volume":"10","author":"Knowles","year":"1996","journal-title":"Hemat Oncol Clin North Am"},{"key":"10.1378\/chest.120.6.1888_bib29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0025-7125(05)70528-9","article-title":"Human immunodeficiency virus-associated lymphomas","volume":"81","author":"Straus","year":"1997","journal-title":"Med Clin North Am"},{"key":"10.1378\/chest.120.6.1888_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00001622-199709050-00009","article-title":"HIV-associated lymphoma","volume":"9","author":"Straus","year":"1997","journal-title":"Curr Opin Oncol"},{"key":"10.1378\/chest.120.6.1888_bib31","first-page":"S27","article-title":"AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy","volume":"21","author":"Grulich","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1378\/chest.120.6.1888_bib32","first-page":"454","article-title":"Acquired immunodeficiency syndrome-related lymphomas: future directions","volume":"27","author":"Porcu","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1378\/chest.120.6.1888_bib33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0272-5231(05)70344-0","article-title":"Pulmonary complications of HIV associated malignancies","volume":"17","author":"White","year":"1996","journal-title":"Clin Chest Med"},{"key":"10.1378\/chest.120.6.1888_bib34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0095-4543(05)70077-4","article-title":"AIDS-related malignancies","volume":"25","author":"Tulpule","year":"1998","journal-title":"Prim Care"},{"key":"10.1378\/chest.120.6.1888_bib35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00002030-200001280-00008","article-title":"B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS","volume":"14","author":"Grulich","year":"2000","journal-title":"AIDS"},{"key":"10.1378\/chest.120.6.1888_bib36","first-page":"1068","article-title":"Epidemiology and pathogenesis of AIDS-related lymphomas","volume":"12","author":"Aboulafia","year":"1998","journal-title":"Oncology"},{"key":"10.1378\/chest.120.6.1888_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00002030-199902040-00005","article-title":"Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients","volume":"13","author":"Foudraine","year":"1999","journal-title":"AIDS"},{"key":"10.1378\/chest.120.6.1888_bib38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-133-6-200009190-00013","article-title":"Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy","volume":"133","author":"DeSimone","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.120.6.1888_bib39","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/jama.283.5.653","article-title":"Cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"283","author":"Whitcup","year":"2000","journal-title":"JAMA"},{"key":"10.1378\/chest.120.6.1888_bib40","first-page":"944","article-title":"Immune mediated \u201cHAART\u201d attack during treatment for tuberculosis","volume":"3","author":"Kunimoto","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1378\/chest.120.6.1888_bib41","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1086\/313705","article-title":"Recurrence of Mycobacterium avium infection in patients receiving highly active antiretroviral therapy and antimycobacterial agents","volume":"30","author":"Cinti","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1378\/chest.120.6.1888_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0190-9622(99)70364-6","article-title":"Sarcoidosis in a patient with AIDS: a manifestation of immune restoration syndrome","volume":"41","author":"Mirmirani","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1378\/chest.120.6.1888_bib43","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1164\/ajrccm.159.6.9807152","article-title":"Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy","volume":"159","author":"Naccache","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.120.6.1888_bib44","first-page":"288S","article-title":"Granulomatous interstitial lung disease in patients with human immunodeficiency virus on highly active antiretroviral therapy","volume":"118","author":"Wohlrab","year":"2000","journal-title":"Chest"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215386189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215386189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T16:01:31Z","timestamp":1553097691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215386189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S0012369215386189"],"URL":"https:\/\/doi.org\/10.1378\/chest.120.6.1888","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}